Care briefing · When to pause
Wait if the answers do not fit together
Look at what is promised, who supplies the medicine, and whether the details can be checked.
Approval language that does not fit
The agency responsible for medicines at the federal level uses the name Food and Drug Administration, abbreviated FDA.
Medicine is made to order in compounding, with a doctor or pharmacist handling the preparation.
As of September 26, 2026, FDA guidance rejects claims of FDA approval for compounded medicines or claims that they are the same as approved drugs.
- Ask for the exact approved product record.
- Ask who actually makes the medicine.
- Keep a copy of the claim if the explanation changes.
A prescription is missing
Federal law checked September 26, 2026 requires a valid prescription before dispensing a prescription medicine.
- Ask who will review your health before deciding whether to write a prescription.
- Ask how that person will follow up on the information you give.
- Ask how you can reach the person who wrote your prescription after receiving medicine.
The pharmacy details do not match
In FDA information checked September 26, 2026, some compounded semaglutide and tirzepatide labels named pharmacies that did not exist.
FDA also warns that convincing online storefronts can be false.
The product is for research, yet marketed for people
In letters reviewed September 26, 2026, FDA warned sellers that injected products can bypass the body’s protections against germs and cause serious harm.
FDA cautions about weight-loss products sold for people to take when the label reads “for research purposes” or, alternatively, “not for human consumption”. Their quality remains unknown, and taking them may cause harm.
“Not for human consumption” means not for people to take.
- Keep the name and advert to discuss with the licensed person treating you.
- Ask whether it is an approved medicine, made for a patient, or labelled only for research.
- Check both the pharmacy and the person who would write the prescription.